Loading company…

AbbVie Inc.

ABBVCIK 000155115215 fiscal years, 54 SEC filings

RevenueFY2025

$61.16B8.6%

Net incomeFY2025

$4.23B1.2%

Free cash flowFY2025

$17.82B0.1%

Diluted EPSFY2025

$2.361.3%

Trends

FY2011–FY2025 · hover a year for its filing

Revenue & net incomeRevenueNet income

revenue 3.5× since FY2011 · net margin 8.9% → 6.9%

MarginsNet marginFCF margin

FY2025: net 6.9% · free cash flow 29.1% of revenue

Cash flowOperating cash flowFree cash flow

FY2025: $19.03B operating cash − $1.21B capex = $17.82B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 102% (FY2014) → -129% (FY2025) · on assets 3.2%

USD millions, except per-share values; share counts in millions. Click a value to open its filing; hover for the XBRL tag.

USD millions	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Revenue	61,160	56,334	54,318	58,054	56,197	45,804	33,266	32,753	28,216	25,638	22,859	19,960
Net income	4,226	4,278	4,863	11,836	11,542	4,616	7,882	5,687	5,309	5,953	5,144	1,774
Diluted EPS	2.36	2.39	2.72	6.63	6.45	2.72	5.28	3.66	3.30	3.63	3.13	1.10
Diluted shares	1,773	1,773	1,773	1,778	1,777	1,673	1,484	1,546	1,603	1,631	1,637	1,610
Operating cash flow	19,030	18,806	22,839	24,943	22,777	17,588	13,324	13,427	9,960	7,041	7,535	3,549
Capital expenditures	1,214	974	777	695	787	798	552	638	529	479	532	612
Free cash flow	17,816	17,832	22,062	24,248	21,990	16,790	12,772	12,789	9,431	6,562	7,003	2,937
Cash & equivalents	5,229	5,524	12,814	9,201	9,746	8,449	39,924	7,289	9,303	5,100	8,399	8,348
Total assets	133,960	135,161	134,711	138,805	146,529	150,565	89,115	59,352	70,786	66,099	53,050	27,513
Shareholders' equity	(3,270)	3,325	10,360	17,254	15,408	13,076	(8,172)	(8,446)	5,097	4,636	3,945	1,742

As reported in SEC filings; a missing tag shows “—”, never zero. Free cash flow is operating cash flow − capex. Methodology